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Abstract 
Background: The COVID‑19 pandemic dramatically influenced the delivery of healthcare. In line with the UK Royal 
Colleges’ advice the management of acute appendicitis (AA) changed with greater consideration for non‑operative 
management (NOM) or open appendicectomy when operative management (OM) was sought. We describe 
our experience of the presentation, management and outcomes for these patients to inform care for future viral 
pandemics.
Methods: This retrospective, cohort study compared patients diagnosed with AA between March and July 2019 with 
those during the pandemic period of March to July 2020. Medical records were reviewed to obtain demographics, 
inflammatory markers, imaging, severity, management, histology, length of stay (LOS) and 90‑day outcomes.
Results: There were 149 and 125 patients in the 2019 and 2020 cohorts respectively. 14 patients (9.4%) had NOM in 
2019 versus 31 (24.8%) in 2020 (p = 0.001). In the 2019 operative management (OM) group 125 patients (92.6%) had 
laparoscopic appendicectomy versus 65 (69.1%) in 2020. 59 patients (39.6%) had a CT in 2019 versus 70 (56%) in 2020. 
The median LOS was 4 days in 2019 and 3 days in 2020 (p = 0.03). Two patients in each year who received NOM had 
treatment failure (14.3% in 2019 and 6.5% in 2020). Three patients in 2019 who received OM had treatment failure 
(2.2%). Of 95 patients tested for COVID‑19 all but one tested negative.
Conclusion: During the COVID‑19 pandemic there was no observed increase in severity of AA, patients had a shorter 
LOS and were more likely to have imaging. NOM proportionally increased with no observed change in outcomes.
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Background
Coronavirus Disease 2019 (COVID-19), caused by the 
severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2), was declared a pandemic by the World Health 
Organisation on 11th March 2020 [1]. During March 
restrictions were put in place on movement and social 
gatherings in an attempt to control viral spread. This 
culminated in United Kingdom (UK) wide ‘lock-down’ on 
the 24th March which led to a reduction in all emergency 
admissions to hospitals across England [2]. A report from 
Italy noted a reduction in presentation of acute appendi-
citis (AA) and worsening severity on presentation [3]; so 
far undocumented in the UK.
On 26th March 2020 the UK Joint Royal Colleges 
published guidance [4] for surgeons working during 
the COVID-19 pandemic advising considerable cau-
tion for all laparoscopic surgery due to the potential risk 
associated with aerosol formation on deflation of the 
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pneumoperitoneum as well as the smoke plume pro-
duced with laparoscopic electrocautery and with high-
energy devices. The Colleges also advised non-operative 
management (NOM) to be used in selected cases and if 
operative management was necessary, an open appendi-
cectomy should be the method of choice.
Acute appendicitis is the most common surgical 
emergency. The classic clinical presentation is present 
in approximately one third of patients with many in the 
extremes of age presenting atypically. Misdiagnosis in 
these age groups is not rare and can lead to an increased 
rate of complications [5]. To avoid complications and the 
associated morbidity early diagnosis and treatment of AA 
is essential.
Prior to the pandemic the general feeling in our Trust 
was that laparoscopic appendicectomy was the preferred 
surgical option over an open approach for the manage-
ment of AA. Part of the reason for this could be that open 
appendicectomy has been associated with greater post-
operative pain, longer hospital admissions and a slower 
return to normal physical activity [6]. Further to this, in 
our Trust NOM was previously felt to be reserved for 
cases where it was the patient’s choice or OM was unfea-
sible in the clinical situation. There is considerable con-
troversy in the literature regarding the role of NOM as 
the first line treatment for AA [7]. NOM for AA at five 
years compared to a primary appendicectomy shows a 
significantly lower post-intervention complication rate by 
avoiding surgical site infection, incisional hernias, post-
operative abscesses, post-operative ileus and other com-
plications [8]. While conflicting evidence shows there is a 
non-significantly higher rate of complicated appendicitis 
with delayed surgery in patients receiving NOM as first-
line therapy [8] and of the patients who have NOM for 
AA there is a 39% risk of recurrence and 27.3% will even-
tually require an interval appendicectomy [9, 10]. This 
highlights some of the controversy that can be found in 
the literature.
During the early stages of the COVID-19 pandemic, 
surgical practice changed for patients with AA as units 
gave greater consideration to the option of NOM and 
open appendicectomy where OM was sought. We 
describe the changes to the management of AA in our 
Trust in response to advice by the Royal Colleges, to 
explore the impact these changes had on short-term out-
comes and to provide insight on some of the lessons we 
have learned as we face the second wave.
Methods
We undertook a single-centre retrospective cohort analy-
sis to compare the management of AA both before and 
during the COVID-19 pandemic. The Royal Devon and 
Exeter Hospital is a University-affiliated NHS Foundation 
Trust with 800 beds offering secondary care specialist 
services to a population of 460,000 people.
All patients discharged with a diagnosis of acute appen-
dicitis during the two study periods were included. Any 
patients relocating to a tertiary centre during their treat-
ment journey and any patients in which acute appendici-
tis was not the primary diagnosis were excluded.
Data were obtained for all patients from the 1st of 
March to the 31st of July 2019 and the equivalent five-
month period in 2020. The 2019 cohort served as a con-
trol for comparison. Electronic health records (EHR) 
were interrogated to obtain baseline demographics, 
patient comorbidities as represented by the American 
Society of Anaesthesiologists (ASA) physical status clas-
sification [11], admission blood tests (C-reactive protein 
(CRP), White Cell Count ((WCC) and platelets), imag-
ing investigations (ultrasound scan (USS) or computed 
tomography (CT) with or without contrast enhancement) 
and outcome data. Management strategy was defined as 
one of the following: non-operative management (NOM) 
with antibiotics; operative management (OM) (with lapa-
roscopic appendicectomy or open appendicectomy).
Operation notes were analysed to grade the severity of 
intra-operative findings in AA according to a nationally 
recognised system shown in Table 1 [12]. Other informa-
tion extracted from the EHR included: hospital length of 
stay (LOS); post-operative complications; re-attendance 
to hospital within 90  days from the initial presentation. 
Symptoms were reviewed daily by medical staff and 
patients were classified as being symptomatic or asymp-
tomatic. COVID-19 tests (for SARS-CoV-2 RNA) were 
taken by trained Health Care Assistants and Nurses; the 
tests had a sensitivity of 71–98% [13].
Histology was reported on all operatively managed 
cases of AA and classified as ‘normal appendix, ‘acute 
inflammation’, ‘tumour’ or ‘other findings’.
Table 1 Intraoperative appearances of acute appendicitis [12]
Non‑complicated Acute Appendicitis
 Grade 0—Normal looking appendix (Endoappendicitis/Periappendici‑
tis)




 Grade 2A—Segmental necrosis (without or little pericolic fluid)
 Grade 2B—Base necrosis (without or little pericolic fluid)
 Grade 3—Inflammatory Tumour
 Grade 3A—Flegmom
 Grade 3B—Abscess < 5 cm without peritoneal free air
 Grade 3C—Abscess > 5 cm without peritoneal free air
 Grade 4—Perforated—diffuse peritonitis with or without peritoneal 
free air
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The primary outcome for this study was treatment 
failure defined as a different treatment strategy to that 
which was originally intended. The secondary outcomes 
were length of stay, re-attendance without treatment fail-
ure and post-operative complications without treatment 
failure.
Data on demographics, blood results and imaging 
modalities used are summarised for the 2019 and 2020 
cohorts (there is access to the raw data in Additional 
file 1). The management of AA (NOM or OM) was com-
pared between cohorts using a Chi-squared test, and 
blood results were compared using two sample t-tests 
and Mann Whitney tests. Within OM patients, surgical 
approaches and histology outcomes are summarised and 
compared between cohorts. Re-attendances are summa-
rised and their management approaches were compared 
between cohorts. Length of stay was compared between 
cohorts using a Mann Whitney test.
Ethical approval was not required due to the retrospec-
tive and anonymised nature of the study. The project 
was registered locally and approved by the clinical audit 
department (reference number 20-4591).
Results
A total of 274 patients were included in this study (149 
in 2019; 125 in 2020). Baseline characteristics, admis-
sion blood results and imaging modalities are reported 
in Table 2. A smaller proportion of patients were treated 
with NOM in the 2019 cohort than in the 2020 cohort 
(14/149 (9.4%) v (29/125 (23.2%)). Two patients in the 
2020 cohort were transferred to a tertiary centre spe-
cialising in paediatric surgery for their ongoing care and 
were excluded from the analysis.
Operative management (OM)
Table  3 shows surgical technique, intraoperative find-
ings and the histology results for the OM patients. There 
was a statistically significant difference between the 
cohorts in terms of the proportion receiving NOM or 
OM (p = 0.001) and having laparoscopic or open surgery 
(p < 0.001).
Morbidity and outcomes
The median length of stay (LOS) in 2019 was 4  days 
(interquartile range (IQR) 3 to 6  days), versus 3  days 
(IQR 2 to 5 days) in 2020 (p = 0.03). The patients who had 
NOM had a median LOS of 5.5 days (IQR 5 to 7 days) in 
the 2019 cohort compared to 3 days (IQR 2 to 6 days) in 
the 2020 cohort. The OM group had a median LOS of 
4  days (IQR 3 to 5  days) in the 2019 cohort and 3  days 
(IQR 2 to 4.8 days) in the 2020 cohort.
In the 2019 cohort, there were two re-attendances 
(14.3%) in the first 90 days in the NOM group—one for 
an appendiceal abscess requiring interventional radio-
logical (IR) drainage and the other for further intrave-
nous antibiotics. Out of 135 patients in the OM group 
there were three reattendances (2.2%)—two patients 
had a post-operative collection and one had a superfi-
cial wound dehiscence.
In the 2020 cohort, two patients (6.5%) in the NOM 
group reattended and required a different management 
strategy—one had an open appendicectomy and the 
other received intravenous antibiotics for an appendi-
ceal abscess confirmed on CT. In the 2020 OM group 
there were no reattendances requiring intervention.
Table 2 Baseline demographics, blood results and imaging 
modality used
≠ (p = 0.75)
¥ (p = 0.03)
× (p = 0.92)
*Ovarian cyst
2019 2020
Number of patients 149 125
Age, in years, mean (SD) 37.2 (21.2) 38.1 (21.0)
Sex, n (%)
 Male 80 (53.7) 67 (53.6)
 Female 69 (46.3) 58 (46.4)
ASA score, n (%)
 I 109 (73.2) 76 (60.8)
 II 27 (18.1) 44 (35.2)
 III 12 (8.1) 5 (4.0)
 IV 1 (0.7) 0 (0)
Admission blood test results
 CRP (mg/L) median (range)≠ 44 (0–494) 37 (0–447)
 WCC (1 ×  109/L) mean (SD) ¥ 13.3 (4.2) 12.3 (3.5)
 Platelets (1 ×  109/L) mean (SD)× 253.3 (68.1) 252.4 (68.5)
Imaging modality, n (%)
 None 58 (38.9) 24 (19.2)
 Ultrasound scan (USS) 32 (21.5) 31 (24.8)
 Computed tomography (CT)¥ 57 (38.3) 64 (51.2)
 USS and CT 2 (1.3) 6 (4.8)
Imaging findings, n (%)
 None 58 (38.9) 24 (19.2)
 Normal/inconclusive 16 (10.7) 8 (6.4)
 Uncomplicated AA 58 (38.9) 70 (56.0)
 Complicated AA 16 (10.7) 23 (18.4)
 Other 1 (1.0)* 0 (0.0)
COVID‑19 N/A
 Not tested, n (%) 149 (100) 30 (24.0)
 Tested, n (%) 0 (0) 95 (76.0)
 Positive 1 (1.1)
 Negative 94 (98.9)
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COVID-19 swab tests became mandatory for all inpa-
tients on 10th April 2020, this equated to 95 patients 
(76%) in the 2020 cohort who were tested. One patient 
tested positive (1.1%) and the remaining 94 (98.9%) who 
were tested were negative. The swab-positive patient was 
originally treated with NOM as the symptoms of acute 
appendicitis coincided with mild COVID-19 symptoms. 
The patient then reattended 14 days later and had a lapa-
roscopic appendicectomy which showed acute inflamma-
tion on histology.
Discussion
The COVID-19 pandemic brought unprecedented chal-
lenges to the National Health Service and drove wide-
spread changes in healthcare delivery. The UK had the 
benefit of witnessing the experiences in other countries 
before a surge in UK COVID-19 cases, allowing our sur-
gical services some time to prepare [3, 14]. The UK Inter-
collegiate guidance [4] encouraged a move towards NOM 
of AA where appropriate. Two recent trials support this 
approach despite the optimum treatment of AA remain-
ing controversial [5, 8, 15, 16].
During the pandemic other General Surgery depart-
ments across the UK were having similar quandaries 
as us in decision-making processes as a result of the 
Royal Colleges’ advice. The HAREM study is an obser-
vational study which looked at 500 patients presenting 
with appendicitis during the first wave of the pandemic 
[15]. Their results were similar to ours showing good 
outcomes in all patients with AA following the intercol-
legiate advice and that NOM is a safe alternative to sur-
gery in uncomplicated AA. Their study provides 30  day 
follow up whereas ours provides 90  day follow up. Our 
study adds to the literature by providing an insight into 
the workings behind a single centre and comparing our 
findings during the pandemic to previous data. This will 
help other similar sized centres in their decision-making 
for future viral pandemics.
Following nationwide ‘lock-down’ in March 2020 fewer 
patients attended with AA (149 in 2019 vs 125 in 2020). 
This finding was not significant and could be a normal 
variation. A larger retrospective study could consider 
evaluating changes in the epidemiology of AA in the 
COVID-19 pandemic. NOM was used more frequently 
(9.4% in 2019 vs 24.8% in 2020) although the major-
ity of patients still received OM. Patient selection for 
NOM appears to be in keeping with the advice provided 
by a recent AA update which advises NOM in patients 
with uncomplicated AA confirmed on imaging [5]. The 
observed reduction in laparoscopic appendicectomy 
(92.6% of OM in 2019 vs 69.1% of OM in 2020; p < 0.001) 
reflects our Trust’s iteration of the Intercollegiate advice 
[4]. More patients re-attended following NOM in both 
years (14.3% of NOM and 2.2% of OM in 2019 vs 6.5% of 
Table 3 Acute appendicitis management and outcomes among patients treated with operative management
± Two began as laparoscopic and were converted to open
≠ Four began as laparoscopic and were converted to open
*Operation note unrecoverable in electronic medical records
Operative management 2019 (N = 135) 2020 (N = 94)
Laparoscopic Surgery, n (%) 125 (92.6) 65 (69.1)
Open 10 (7.4)± 28 (29.7)≠
Unknown 0 (0.0) 1 (2.1)*
Intraoperative findings, n (%)
 Grade 0 5 (3.7) 3 (3.2)
 Grade 1 72 (53.3) 55 (58.5)
 Grade 2a 9 (6.7) 7 (7.4)
 Grade 2b 2 (1.5) 3 (3.2)
 Grade 3a 10 (7.4) 5 (5.3)
 Grade 3b 18 (13.3) 7 (7.4)
 Grade 3c 2 (1.5) 1 (1.1)
 Grade 4 17 (12.6) 10 (10.7)
Histology, n (%)
 Acute inflammation 122 (90.4) 88 (93.4)
 Tumour 1 (0.7) adenocarcinoma
3 (2.2) mucinous neoplasm
1 (0.7) neuroendocrine
0
 Other 5 (3.7) normal appendix
1 (2.1) chronic inflammation
3 (3.2) normal appendix
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NOM and 0% of OM in 2020). There was no adverse out-
come for these patients who reattended. They had imag-
ing, an extension of their antibiotic regime, reassurance 
or symptom control. This serves to make the point that 
although we have observed no significant morbidity with 
NOM there has still been use of healthcare resources 
and this is important to consider in the balance between 
NOM and OM in uncomplicated AA.
The current pandemic presents unquantified risks to 
patients. Some early collaborative trials showed there 
was an increased risk of morbidity and mortality in 
COVID-19 positive patients undergoing surgery [17]. 
For surgeons this translates to new challenges in con-
sent and shared decision-making. As the COVID-19 out-
break progressed our consent process changed to counsel 
patients on the risks associated with contracting the virus 
during the perioperative period. In 2019, 59 patients 
(39.5%) had a CT compared to 70 patients (56%) in 2020. 
This was to improve diagnostics and to guide appropriate 
management reducing unnecessary operating. Clinical 
decision-making and available resources are part of the 
reason that not all cases had imaging. Recent published 
guidance pushes towards imaging rather than diagnostic 
laparoscopy [18] and we had a lower negative appendi-
cectomy rate in both cohorts (3.7% in 2019 and 3.2% in 
2020) when compared with the literature [19, 20]. There 
is evidence that COVID-19 infection can clinically mimic 
AA in atypical cases [21] but none of the patients with 
a negative appendicectomy had COVID-19 confirmed on 
swab.
Patients presenting with AA during the COVID-19 
pandemic had shorter hospital stays. This was the case 
for patients following an operation (median of 4 days in 
2019 vs 3  days in 2020) despite evidence showing that 
open appendicectomies result in longer hospital admis-
sions [6]. During the pandemic there were non-clinical 
factors which drove prompt discharges compared to nor-
mal circumstances such as pressure from senior manage-
ment to increase bed capacity as well as patient choice to 
reduce their risk of exposure to the virus. These findings 
suggest that under normal circumstances we may be able 
to safely discharge patients earlier who are recovering 
from AA. This is supported by recent evidence demon-
strating that OM of AA can be conducted as a day case in 
25% of patients [22].
In this study, there are several limitations. It is a ret-
rospective study and captures a small cohort of patients 
from a single-centre. However, it represents data from 
a large district general hospital and other studies have 
reported similar findings [15, 16] We cannot com-
ment if patients re-attended out of area though this 
seems unlikely with Government advice to avoid non-
essential travel [23]. The authors would have included a 
comparison on the rate of delayed presentation and rate 
of perforated appendicitis between the two study peri-
ods. However, given the retrospective and observational 
nature of the study we relied on thorough clinical docu-
mentation of time of symptom onset which unfortunately 
was not available consistently or accurately. This is some-
thing that could be considered in similar prospective 
studies in the future.
In one sense the pandemic has presented an oppor-
tunity to put alternative approaches to the test. Easing 
of the preventive measures has demonstrated an evolv-
ing second peak of the virus and pressure on the health 
services may be worse than the first [24]. This study has 
demonstrated few complications following NOM and 
subsequently our Trust is open to NOM in uncompli-
cated AA. Along with the strengthening body of evidence 
in support of this management strategy we are more 
equipped to counsel patients to make informed decisions 
about their care.
Conclusions
During the early months of the COVID-19 pandemic, 
we saw no increase in the severity of acute appendicitis 
presentations. In our department, more patients were 
managed without surgery, and spent less time in hospital. 
Consistent with other studies, we saw no significant dif-
ference in outcomes. We recognise the need for further 
studies to assess longer-term outcomes, but this study 
adds to the case for a non-operative first line approach to 
acute appendicitis.
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